Loading
Archives of Clinical Toxicology
ISSN: 2692-8280
Most Cited Articles
Valproate, Topiramate, and emerging neurodevelopmental concerns
Chiara Gazerro, Carla Landolfi
Our brain is the most intricated organ of our body. It is, therefore, unsurprising that external factors to which the fetus is exposed to during its development, such as drugs, alcohol, environmental toxicants, and medicines may have lasting effects that extend into adulthood [1,2].
Arch Clin Toxicol, 2024, Volume 6, Issue 1, p16-18 | DOI: 10.46439/toxicology.6.027
Non-alcoholic fatty liver disease: Role of nuclear receptor superfamily members and approaches to treatment
Siddique Rezan Mohammed, Shakil A Saghir, M.Sc., M.S.P.H., Ph.D., DABT, ERT, Fellow ATS, Fellow RSB, Saleh Alfuraih, Abdulaziz Khalid Salamatullah, Faisal Fahad Alnefaie, Samirah Khan, Syed A. A. Rizvi, Rais Ansari, Ph.D.
Non-alcoholic fatty liver disease (NAFLD) is an increasing health problem when left untreated. NAFLD is defined as accumulation of fat in 5% of the hepatocytes. NAFLD can convert into non-alcoholic steatohepatitis (NASH) which is defined as inflammatory NAFLD. Both NAFLD and NASH are observed in individuals suffering from metabolic syndrome and type 2 diabetes (T2D).
Arch Clin Toxicol, 2024, Volume 6, Issue 1, p48-61 | DOI: 10.46439/toxicology.6.031